Why the study?
Indices of coronary microvascular dysfunction are influenced by haemodynamic conditions and may vary depending on the hyperaemic agent used. However, the effect of different hyperaemic agents such as ATP and nicorandil on invasively derived microvascular indices had not been adequately evaluated in direct within-patient comparisons.
Does continuous intravenous adenosine triphosphate (ATP) compared with intracoronary nicorandil alter the measurement and interpretation of invasive coronary microvascular function indices in patients with suspected INOCA?
Observational (n=47)
Does continuous intravenous adenosine triphosphate (ATP) compared with intracoronary nicorandil alter the measurement and interpretation of invasive coronary microvascular function indices in patients with suspected INOCA?
Intravenous ATP induces a greater drop in systemic blood pressure and yields significantly lower coronary flow reserve values compared with intracoronary nicorandil in INOCA patients, whereas IMR and MRR remain consistent across both agents.
ATP yields lower CFR than nicorandil in INOCA; leaves open whether IMR/MRR should standardize microvascular assessment across agents.
Introduction Invasive assessment of coronary microvascular function relies on pharmacologically induced maximum hyperaemia; however, the interpretation of derived physiological indices may be influenced by the choice of hyperaemic agent. Adenosine triphosphate (ATP) and nicorandil are commonly used, but they differ in their systemic haemodynamic effects, including blood pressure changes. Unlike fractional flow reserve, indices of coronary microvascular dysfunction are influenced by haemodynamic conditions; therefore, measured values may vary depending on the hyperaemic agent used. Nevertheless, the effect of different hyperaemic agents on invasively derived microvascular indices has not been adequately evaluated in direct within-patient comparisons. Purpose This study aimed to determine whether the choice of hyperaemic agent influences the interpretation of invasive microvascular function in patients with suspected ischaemia and non-obstructive coronary arteries (INOCA). Methods This prospective observational study enrolled patients with suspected INOCA without significant epicardial stenosis (fractional flow reserve (FFR) ≧0.80). Coronary physiology of the left anterior descending artery was assessed using a pressure wire and bolus thermodilution technique. Maximum hyperaemia was induced by continuous intravenous ATP infusion (180 μg/kg/min) and intracoronary nicorandil (2 mg), with both agents administered in each patient. The sequence of administration was at operator discretion. A ≧5-minute washout period was observed, and the second agent was administered only after confirmation that heart rate and blood pressure had returned to baseline, to minimise potential order effects. Results A total of 47 patients were analysed. In comparison with nicorandil, ATP was associated with a significantly greater reduction in blood pressure (ΔBP) (14.6 ± 9.84 mmHg vs. 7.63 ± 6.12 mmHg; p < 0.001). Coronary flow reserve (CFR) was significantly lower during ATP-induced hyperaemia than during nicorandil-induced hyperaemia (geometric mean ratio (GMR) [ATP/nicorandil] 0.83, 95% CI 0.73–0.95; p=0.007). In contrast, index of microcirculatory resistance (IMR) and microvascular resistance reserve (MRR) exhibited comparable characteristics across the agents (IMR: GMR 1.07, 95% CI 0.94–1.22; p=0.27; MRR: GMR 0.95, 95% CI 0.84–1.07; p=0.386). The FFR values were comparable (0.91 ± 0.03 vs. 0.91 ± 0.03; p=0.33). Conclusions In comparison with intracoronary nicorandil, intravenous ATP resulted in a greater decrease in blood pressure and a lower CFR, while IMR, MRR and FFR were comparable. These findings suggest that systemic blood pressure changes induced by hyperaemic agents may influence the interpretation of CFR and should be taken into consideration when assessing coronary microvascular function. In this context, evaluation using MRR, which accounts for haemodynamic conditions, may provide a complementary approach for microvascular assessment.
No takes yet. Share an insight, caveat, or question.
Shimoda et al. (2026) conducted an observational in Suspected ischaemia and non-obstructive coronary arteries (INOCA) (n=47). Intravenous adenosine triphosphate (ATP) vs. Intracoronary nicorandil (2 mg) was evaluated on Coronary flow reserve (CFR) (GMR 0.83, 95% CI 0.73-0.95, p=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: